Export 2757 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
V. T. Ho, Cutler, C., Carter, S., Martin, P., Adams, R., Horowitz, M., Ferrara, J., Soiffer, R., and Giralt, S., “Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.”, Biol Blood Marrow Transplant, vol. 11, no. 8, pp. 571-5, 2005.
A. Matthews, Hu, L., Lu, L., and Van Veldhuisen, P., “Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN)”, in College on Problems of Drug Dependence Meeting, San Diego, CA, 2013.
G. M. O’Kane, JL, S., P, K., RA, G., E, M. W., D, T., M, J., ER, M. A., ER, M. A., A, M., L, W., and J, P., “BOLD-100-001 (TRIO039): A phase Ib Dose-escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Gastrointestinal Solid Tumors”, in ASCO Annual Meeting, 2021.
J. Light, Salomon, D. R., Diethelm, A. G., J Alexander, W., Hunsicker, L., Thistlethwaite, R., Reinsmoen, N., and Stablein, D. M., “Bone marrow transfusions in cadaver renal allografts: pilot trials with concurrent controls.”, Clin Transplant, vol. 16, no. 5, pp. 317-24, 2002.
C. Groh and Rosenmayr, F. W., “[Borderline between antiepileptic and psychopharmacological drugs (author's transl)].”, Padiatr Padol, vol. 10, no. 2, pp. 131-9, 1975.
K. Meador, Baker, G., Browning, N., Clayton-Smith, J., Combs-Cantrell, D., Cohen, M., Kalayjian, L., Kanner, A., Liporace, J., Pennell, P., Privitera, M., Loring, D., and Group, N. E. A. D. Study, “Breastfeeding in Children of Women on Antiepileptic Drugs”, Neurology, vol. 75, pp. 1954-1960, 2010.
K. J. Meador, Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., Loring, D. W., and Group, T. Neurodevel, “Breastfeeding in Children of Women Taking Antiepileptic Drugs: Cognitive Outcomes at Age 6 Years”, JAMA Pediatr, vol. 168, pp. 729-736, 2014.
K. J. Meador, Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., and Loring, D. W., “Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.”, JAMA Pediatr, vol. 168, no. 8, pp. 729-36, 2014.
M. P. Bogenschutz, Donovan, D. M., Mandler, R. N., Perl, H. I., Forcehimes, A. A., Crandall, C., Lindblad, R., Oden, N. L., Sharma, G., Metsch, L., Lyons, M. S., McCormack, R., Konstantopoulos, W. M., and Douaihy, A., “Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments: A Randomized Clinical Trial”, JAMA Intern Med, vol. 174, pp. 1736-1745, 2014.
M. P. Bogenschutz, Donovan, D. M., Mandler, R. N., Perl, H. I., Forcehimes, A. A., Crandall, C., Lindblad, R., Oden, N. L., Sharma, G., Metsch, L., Lyons, M. S., McCormack, R., Macias-Konstantopoulos, W., and Douaihy, A., “Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial.”, JAMA Intern Med, vol. 174, no. 11, pp. 1736-45, 2014.
A. M. Bunting, Schwartz, R. P., Wu, L. - T., Wahle, A., Kline, M., Subramaniam, G., and McNeely, J., “A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool.”, J Addict Med, vol. 17, no. 4, pp. 471-473, 2023.
L. D. Hubbard, Danis, R. P., Neider, M. W., Wabers, H. D., Thayer, D. W., and Group, A. - R. Eye Diseas, “Brightness, Contrast, and Color Balance of Digital vs. Film Retinal Images in the Age-Related Eye Disease Study 2”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2008.
A. Lindblad, “Bringing Better Treatments to Patients Faster by Expanding Access”, Arch Ophthalmol, vol. 127, pp. 1674-1675, 2009.
A. S. Lindblad, “Bringing better treatments to patients faster by expanding access.”, Arch Ophthalmol, vol. 127, no. 12, pp. 1674-5, 2009.
G. Mutua, Farah, B., Langat, R., Indangasi, J., Ogola, S., Onsembe, B., Kopycinski, J. T., Hayes, P., Borthwick, N. J., Ashraf, A., Dally, L., Barin, B., Tillander, A., Gilmour, J., De Bont, J., Crook, A., Hannaman, D., Cox, J. H., Anzala, O., Fast, P. E., Reilly, M., Chinyenze, K., Jaoko, W., Hanke, T., and Group, T. Hiv- Core 0, “Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.”, Mol Ther Methods Clin Dev, vol. 3, p. 16061, 2016.
C. C. Gotay, Korn, E. L., McCabe, M. S., Moore, T. D., and Cheson, B. D., “Building quality of life assessment into cancer treatment studies.”, Oncology (Williston Park), vol. 6, no. 6, pp. 25-8; discussion 30-2, 37, 1992.
W. Ling, Hillhouse, M. P., Saxon, A. J., Mooney, L. J., Thomas, C. M., Ang, A., Matthews, A. G., Hasson, A., Annon, J., Sparenborg, S., Liu, D. S., McCormack, J., Church, S., Swafford, W., Drexler, K., Schuman, C., Ross, S., Wiest, K., P Korthuis, T., Lawson, W., Brigham, G. S., Knox, P. C., Dawes, M., and Rotrosen, J., “Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.”, Addiction, vol. 111, no. 8, pp. 1416-27, 2016.
L. - T. Wu, John, W. S., Ghitza, U. E., Wahle, A., Matthews, A. G., Lewis, M., Hart, B., Hubbard, Z., Bowlby, L. A., Greenblatt, L. H., and Mannelli, P., “Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.”, Addiction, 2021.
M. H. Trivedi, Walker, R., Ling, W., Cruz, A. Dela, Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., Sparenborg, S., Coffin, P., Schmitz, J., Wiest, K., Bart, G., Sonne, S. C., Wakhlu, S., A Rush, J., Nunes, E. V., and Shoptaw, S., “Bupropion and Naltrexone in Methamphetamine Use Disorder”, N Engl J Med, vol. 384, no. 2, pp. 140-153, 2021.
D. Wall, Carter, S. L., Kapoor, N., Kamani, N., Kernan, N., Jensen, L., Brochstein, J., Frangoul, H., Goyal, R., Horan, J., Pietryga, D., Wagner, J., and Kurtzberg, J., “Busulfan/melphalan/ATG (Bu/Mel/ATG) as a preparative regimen for unrelated donor cord blood transplantation (UCBT): the COBLT experience”, 2003.
C
A. Tejani, Stablein, D. M., and Ho, P. L., “Calculated Creatinine Clearance (CCC) as the Most Promising Candidate Surrogate End Point for Clinical Trials”, 2002.
T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., Tartaglia, J., and Group, theN. I. A. I. D. A. I. D. S., “A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers”, J Infec Dis, vol. 180, pp. 290-8, 1999.
T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., and Tartaglia, J., “A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.”, J Infect Dis, vol. 180, no. 2, pp. 290-8, 1999.
R. R. Sokal, Oden, N. L., Rosenberg, M. S., and Thomson, B. A., “Cancer incidences in Europe related to mortalities, and ethnohistoric, genetic, and geographic distances.”, Proc Natl Acad Sci U S A, vol. 97, no. 11, pp. 6067-72, 2000.
R. R. Sokol, Oden, N. L., Rosenberg, M. S., and Thomson, B. A., “Cancer incidences in Europe related to mortalities, ethnohistoric, genetic, and geographic distances”, Proceedings of the National Academy of Science, vol. 97, pp. 6067-72, 2000.